Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.

Xavier Garcia-del-Muro,Joan Maurel,Javier Martínez Trufero,J. Lavernia,Antonio Lopez-Pousa,Ramon De Las Penas,Ricardo Cubedo,Joaquin Fra,Antonio Casado,Ana de Juan,Laura Jimenez Colomo,Javier Martin Broto

Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.

2017

Xavier Garcia-del-Muro
Joan Maurel
Javier Martínez Trufero
J. Lavernia
Antonio Lopez-Pousa
Ramon De Las Penas
Ricardo Cubedo
Joaquin Fra
Antonio Casado
Ana de Juan
Laura Jimenez Colomo
Javier Martin Broto

10523 Background: Recent studies suggest that VEGFR inhibition could play a role in the treatment of soft tissue sarcoma (STS). Prior studies by our group showed that the combination of ifosfamide ...

Keywords:

Pathology
VEGF receptors
Soft tissue sarcoma
Ifosfamide
Sorafenib
Internal medicine
Oncology
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations